|
|
Blood, 1 January 2008, Vol. 111, No. 1, pp. 387-391.
Prepublished online as a Blood First Edition Paper on October 16, 2007; DOI 10.1182/blood-2007-07-092015.
Previous Article | Next Article 
Submitted July 2, 2007
Accepted September 19, 2007
t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukaemia (BCP-ALL)
Lisa J Russell, Takashi Akasaka, Aneela Majid, Kei-ji Sugimoto, E. Loraine Karran, Inga Nagel, Lana Harder, Alexander Claviez, Stefan Gesk, Anthony V. Moorman, Fiona Ross, Helen Mazzullo, Jonathan C. Strefford, Reiner Siebert, Martin J.S. Dyer, and Christine J. Harrison*
Leukaemia Research Cytogenetics, Cancer Sciences Division, University of Southampton, Southampton, United Kingdom
Medical Research Council (MRC) Toxicology Unit, University of Leicester, Leicester, United Kingdom
Institute of Human Genetics, University Hospital Schleswig-Holstein, Kiel, Germany
Wessex Regional Genetics Laboratory, University of Southampton, Salisbury, United Kingdom
Department of Haematology, University College Hospital, London, United Kingdom
* Corresponding author; email: harrison{at}soton.ac.uk.
Translocations involving the immunoglobulin heavy chain locus (IGH@) at chromosome band 14q32 are common in mature B-cell neoplasms, but are rare in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Here, we report the translocation, t(6;14)(p22;q32), involving IGH@ as a novel recurrent translocation in 13 BCP-ALL patients. Fluorescence in situ hybridization and long-distance inverse polymerase chain reaction identified ID4 as the partner gene. Breakpoints were scattered over a 19kb region centromeric of ID4. Quantitative real-time PCR showed upregulation of ID4 mRNA. All patients had deletions of CDKN2A and PAX5 located on the short arm of chromosome 9, frequently as a result of an isochromosome, i(9)(q10) (9/13, 69%). This study defines a new subgroup of BCP-ALL characterized by ID4 over-expression and CDKN2A and PAX5 deletions. Preliminary survival data suggest that this subgroup may be associated with a good response to therapy.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. J. Russell, M. Capasso, I. Vater, T. Akasaka, O. A. Bernard, M. J. Calasanz, T. Chandrasekaran, E. Chapiro, S. Gesk, M. Griffiths, et al.
Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia
Blood,
September 24, 2009;
114(13):
2688 - 2698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sulong, A. V. Moorman, J. A. E. Irving, J. C. Strefford, Z. J. Konn, M. C. Case, L. Minto, K. E. Barber, H. Parker, S. L. Wright, et al.
A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups
Blood,
January 1, 2009;
113(1):
100 - 107.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|